nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Erythema multiforme—Etoposide—prostate cancer	0.00135	0.00152	CcSEcCtD
Betahistine—Discomfort—Estradiol—prostate cancer	0.00135	0.00152	CcSEcCtD
Betahistine—Malaise—Mitoxantrone—prostate cancer	0.00135	0.00152	CcSEcCtD
Betahistine—Dizziness—Ethinyl Estradiol—prostate cancer	0.00133	0.00149	CcSEcCtD
Betahistine—Confusional state—Estradiol—prostate cancer	0.00132	0.00149	CcSEcCtD
Betahistine—Urticaria—Goserelin—prostate cancer	0.00131	0.00148	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.00131	0.00147	CcSEcCtD
Betahistine—Anaphylactic shock—Estradiol—prostate cancer	0.00131	0.00147	CcSEcCtD
Betahistine—Urticaria—Conjugated Estrogens—prostate cancer	0.0013	0.00146	CcSEcCtD
Betahistine—Convulsion—Mitoxantrone—prostate cancer	0.00129	0.00146	CcSEcCtD
Betahistine—Immune system disorder—Etoposide—prostate cancer	0.00129	0.00145	CcSEcCtD
Betahistine—Abdominal distension—Prednisone—prostate cancer	0.00129	0.00145	CcSEcCtD
Betahistine—Nervous system disorder—Estradiol—prostate cancer	0.00128	0.00144	CcSEcCtD
Betahistine—Tachycardia—Estradiol—prostate cancer	0.00128	0.00144	CcSEcCtD
Betahistine—Vomiting—Ethinyl Estradiol—prostate cancer	0.00128	0.00144	CcSEcCtD
Betahistine—Skin disorder—Estradiol—prostate cancer	0.00127	0.00143	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.00127	0.00143	CcSEcCtD
Betahistine—Rash—Ethinyl Estradiol—prostate cancer	0.00126	0.00142	CcSEcCtD
Betahistine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00126	0.00142	CcSEcCtD
Betahistine—Discomfort—Mitoxantrone—prostate cancer	0.00126	0.00141	CcSEcCtD
Betahistine—Headache—Ethinyl Estradiol—prostate cancer	0.00126	0.00141	CcSEcCtD
Betahistine—Confusional state—Mitoxantrone—prostate cancer	0.00123	0.00138	CcSEcCtD
Betahistine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00122	0.00137	CcSEcCtD
Betahistine—Hypersensitivity—Goserelin—prostate cancer	0.00122	0.00137	CcSEcCtD
Betahistine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.0012	0.00136	CcSEcCtD
Betahistine—Nausea—Ethinyl Estradiol—prostate cancer	0.00119	0.00134	CcSEcCtD
Betahistine—Tachycardia—Mitoxantrone—prostate cancer	0.00119	0.00134	CcSEcCtD
Betahistine—Asthenia—Goserelin—prostate cancer	0.00118	0.00133	CcSEcCtD
Betahistine—Skin disorder—Mitoxantrone—prostate cancer	0.00118	0.00133	CcSEcCtD
Betahistine—Asthenia—Conjugated Estrogens—prostate cancer	0.00117	0.00132	CcSEcCtD
Betahistine—Pruritus—Goserelin—prostate cancer	0.00117	0.00131	CcSEcCtD
Betahistine—Dyspnoea—Estradiol—prostate cancer	0.00117	0.00131	CcSEcCtD
Betahistine—Somnolence—Estradiol—prostate cancer	0.00116	0.00131	CcSEcCtD
Betahistine—Pruritus—Conjugated Estrogens—prostate cancer	0.00116	0.0013	CcSEcCtD
Betahistine—Ill-defined disorder—Etoposide—prostate cancer	0.00115	0.0013	CcSEcCtD
Betahistine—Dyspepsia—Estradiol—prostate cancer	0.00115	0.0013	CcSEcCtD
Betahistine—Gastrointestinal disorder—Estradiol—prostate cancer	0.00113	0.00127	CcSEcCtD
Betahistine—Diarrhoea—Goserelin—prostate cancer	0.00113	0.00127	CcSEcCtD
Betahistine—Fatigue—Estradiol—prostate cancer	0.00113	0.00127	CcSEcCtD
Betahistine—Erythema multiforme—Docetaxel—prostate cancer	0.00112	0.00126	CcSEcCtD
Betahistine—Malaise—Etoposide—prostate cancer	0.00112	0.00126	CcSEcCtD
Betahistine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00112	0.00126	CcSEcCtD
Betahistine—Dizziness—Goserelin—prostate cancer	0.00109	0.00123	CcSEcCtD
Betahistine—Dyspnoea—Mitoxantrone—prostate cancer	0.00109	0.00122	CcSEcCtD
Betahistine—Erythema multiforme—Capecitabine—prostate cancer	0.00109	0.00122	CcSEcCtD
Betahistine—Somnolence—Mitoxantrone—prostate cancer	0.00108	0.00122	CcSEcCtD
Betahistine—Dizziness—Conjugated Estrogens—prostate cancer	0.00108	0.00122	CcSEcCtD
Betahistine—Feeling abnormal—Estradiol—prostate cancer	0.00108	0.00121	CcSEcCtD
Betahistine—Convulsion—Etoposide—prostate cancer	0.00108	0.00121	CcSEcCtD
Betahistine—Dyspepsia—Mitoxantrone—prostate cancer	0.00107	0.00121	CcSEcCtD
Betahistine—Immune system disorder—Docetaxel—prostate cancer	0.00107	0.00121	CcSEcCtD
Betahistine—Orthostatic hypotension—Epirubicin—prostate cancer	0.00106	0.00119	CcSEcCtD
Betahistine—Abdominal pain upper—Epirubicin—prostate cancer	0.00106	0.00119	CcSEcCtD
Betahistine—Fatigue—Mitoxantrone—prostate cancer	0.00105	0.00118	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.00105	0.00118	CcSEcCtD
Betahistine—Vomiting—Goserelin—prostate cancer	0.00105	0.00118	CcSEcCtD
Betahistine—Discomfort—Etoposide—prostate cancer	0.00105	0.00118	CcSEcCtD
Betahistine—Rash—Goserelin—prostate cancer	0.00104	0.00117	CcSEcCtD
Betahistine—Dermatitis—Goserelin—prostate cancer	0.00104	0.00117	CcSEcCtD
Betahistine—Vomiting—Conjugated Estrogens—prostate cancer	0.00104	0.00117	CcSEcCtD
Betahistine—Urticaria—Estradiol—prostate cancer	0.00104	0.00117	CcSEcCtD
Betahistine—Immune system disorder—Capecitabine—prostate cancer	0.00104	0.00117	CcSEcCtD
Betahistine—Headache—Goserelin—prostate cancer	0.00103	0.00116	CcSEcCtD
Betahistine—Rash—Conjugated Estrogens—prostate cancer	0.00103	0.00116	CcSEcCtD
Betahistine—Dermatitis—Conjugated Estrogens—prostate cancer	0.00103	0.00116	CcSEcCtD
Betahistine—Headache—Conjugated Estrogens—prostate cancer	0.00102	0.00115	CcSEcCtD
Betahistine—Confusional state—Etoposide—prostate cancer	0.00102	0.00115	CcSEcCtD
Betahistine—Hallucination—Prednisone—prostate cancer	0.00102	0.00115	CcSEcCtD
Betahistine—Anaphylactic shock—Etoposide—prostate cancer	0.00101	0.00114	CcSEcCtD
Betahistine—Abdominal distension—Epirubicin—prostate cancer	0.00101	0.00113	CcSEcCtD
Betahistine—Feeling abnormal—Mitoxantrone—prostate cancer	0.001	0.00113	CcSEcCtD
Betahistine—Asthma—Epirubicin—prostate cancer	0.001	0.00113	CcSEcCtD
Betahistine—Tachycardia—Etoposide—prostate cancer	0.00099	0.00111	CcSEcCtD
Betahistine—Flatulence—Capecitabine—prostate cancer	0.000985	0.00111	CcSEcCtD
Betahistine—Skin disorder—Etoposide—prostate cancer	0.000985	0.00111	CcSEcCtD
Betahistine—Nausea—Goserelin—prostate cancer	0.00098	0.0011	CcSEcCtD
Betahistine—Abdominal pain upper—Doxorubicin—prostate cancer	0.000977	0.0011	CcSEcCtD
Betahistine—Orthostatic hypotension—Doxorubicin—prostate cancer	0.000977	0.0011	CcSEcCtD
Betahistine—Nausea—Conjugated Estrogens—prostate cancer	0.000971	0.00109	CcSEcCtD
Betahistine—Urticaria—Mitoxantrone—prostate cancer	0.000969	0.00109	CcSEcCtD
Betahistine—Hypersensitivity—Estradiol—prostate cancer	0.000964	0.00109	CcSEcCtD
Betahistine—Asthenia—Estradiol—prostate cancer	0.000939	0.00106	CcSEcCtD
Betahistine—Abdominal distension—Doxorubicin—prostate cancer	0.000931	0.00105	CcSEcCtD
Betahistine—Ill-defined disorder—Capecitabine—prostate cancer	0.000928	0.00104	CcSEcCtD
Betahistine—Pruritus—Estradiol—prostate cancer	0.000926	0.00104	CcSEcCtD
Betahistine—Asthma—Doxorubicin—prostate cancer	0.000925	0.00104	CcSEcCtD
Betahistine—Immune system disorder—Prednisone—prostate cancer	0.000924	0.00104	CcSEcCtD
Betahistine—Dyspnoea—Etoposide—prostate cancer	0.000904	0.00102	CcSEcCtD
Betahistine—Malaise—Capecitabine—prostate cancer	0.000902	0.00101	CcSEcCtD
Betahistine—Somnolence—Etoposide—prostate cancer	0.000902	0.00101	CcSEcCtD
Betahistine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000898	0.00101	CcSEcCtD
Betahistine—Diarrhoea—Estradiol—prostate cancer	0.000895	0.00101	CcSEcCtD
Betahistine—Convulsion—Docetaxel—prostate cancer	0.000895	0.00101	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000884	0.000995	CcSEcCtD
Betahistine—Gastrointestinal disorder—Etoposide—prostate cancer	0.000876	0.000986	CcSEcCtD
Betahistine—Asthenia—Mitoxantrone—prostate cancer	0.000875	0.000985	CcSEcCtD
Betahistine—Fatigue—Etoposide—prostate cancer	0.000874	0.000984	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000873	0.000983	CcSEcCtD
Betahistine—Dizziness—Estradiol—prostate cancer	0.000865	0.000974	CcSEcCtD
Betahistine—Confusional state—Docetaxel—prostate cancer	0.00085	0.000957	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000845	0.000952	CcSEcCtD
Betahistine—Anaphylactic shock—Docetaxel—prostate cancer	0.000843	0.000949	CcSEcCtD
Betahistine—Discomfort—Capecitabine—prostate cancer	0.000841	0.000947	CcSEcCtD
Betahistine—Feeling abnormal—Etoposide—prostate cancer	0.000836	0.000941	CcSEcCtD
Betahistine—Diarrhoea—Mitoxantrone—prostate cancer	0.000834	0.000939	CcSEcCtD
Betahistine—Vomiting—Estradiol—prostate cancer	0.000832	0.000936	CcSEcCtD
Betahistine—Nervous system disorder—Docetaxel—prostate cancer	0.000827	0.00093	CcSEcCtD
Betahistine—Ill-defined disorder—Prednisone—prostate cancer	0.000826	0.00093	CcSEcCtD
Betahistine—Rash—Estradiol—prostate cancer	0.000825	0.000929	CcSEcCtD
Betahistine—Dermatitis—Estradiol—prostate cancer	0.000824	0.000928	CcSEcCtD
Betahistine—Confusional state—Capecitabine—prostate cancer	0.000823	0.000926	CcSEcCtD
Betahistine—Tachycardia—Docetaxel—prostate cancer	0.000823	0.000926	CcSEcCtD
Betahistine—Headache—Estradiol—prostate cancer	0.00082	0.000923	CcSEcCtD
Betahistine—Skin disorder—Docetaxel—prostate cancer	0.000819	0.000921	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000818	0.00092	CcSEcCtD
Betahistine—Angioedema—Prednisone—prostate cancer	0.000814	0.000916	CcSEcCtD
Betahistine—Urticaria—Etoposide—prostate cancer	0.000806	0.000907	CcSEcCtD
Betahistine—Malaise—Prednisone—prostate cancer	0.000803	0.000904	CcSEcCtD
Betahistine—Nervous system disorder—Capecitabine—prostate cancer	0.0008	0.000901	CcSEcCtD
Betahistine—Tachycardia—Capecitabine—prostate cancer	0.000796	0.000896	CcSEcCtD
Betahistine—Skin disorder—Capecitabine—prostate cancer	0.000793	0.000892	CcSEcCtD
Betahistine—Nausea—Estradiol—prostate cancer	0.000777	0.000875	CcSEcCtD
Betahistine—Vomiting—Mitoxantrone—prostate cancer	0.000775	0.000873	CcSEcCtD
Betahistine—Convulsion—Prednisone—prostate cancer	0.000772	0.000869	CcSEcCtD
Betahistine—Rash—Mitoxantrone—prostate cancer	0.000769	0.000865	CcSEcCtD
Betahistine—Dermatitis—Mitoxantrone—prostate cancer	0.000768	0.000865	CcSEcCtD
Betahistine—Headache—Mitoxantrone—prostate cancer	0.000764	0.00086	CcSEcCtD
Betahistine—Erythema multiforme—Epirubicin—prostate cancer	0.000757	0.000852	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000753	0.000848	CcSEcCtD
Betahistine—Dyspnoea—Docetaxel—prostate cancer	0.000751	0.000846	CcSEcCtD
Betahistine—Somnolence—Docetaxel—prostate cancer	0.000749	0.000843	CcSEcCtD
Betahistine—Discomfort—Prednisone—prostate cancer	0.000749	0.000843	CcSEcCtD
Betahistine—Hypersensitivity—Etoposide—prostate cancer	0.000747	0.000841	CcSEcCtD
Betahistine—Dyspepsia—Docetaxel—prostate cancer	0.000742	0.000835	CcSEcCtD
Betahistine—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000728	0.000819	CcSEcCtD
Betahistine—Asthenia—Etoposide—prostate cancer	0.000728	0.000819	CcSEcCtD
Betahistine—Dyspnoea—Capecitabine—prostate cancer	0.000727	0.000819	CcSEcCtD
Betahistine—Anaphylactic shock—Prednisone—prostate cancer	0.000727	0.000818	CcSEcCtD
Betahistine—Fatigue—Docetaxel—prostate cancer	0.000727	0.000818	CcSEcCtD
Betahistine—Nausea—Mitoxantrone—prostate cancer	0.000724	0.000815	CcSEcCtD
Betahistine—Immune system disorder—Epirubicin—prostate cancer	0.000723	0.000814	CcSEcCtD
Betahistine—Dyspepsia—Capecitabine—prostate cancer	0.000718	0.000809	CcSEcCtD
Betahistine—Pruritus—Etoposide—prostate cancer	0.000717	0.000808	CcSEcCtD
Betahistine—Nervous system disorder—Prednisone—prostate cancer	0.000713	0.000802	CcSEcCtD
Betahistine—Tachycardia—Prednisone—prostate cancer	0.000709	0.000799	CcSEcCtD
Betahistine—Skin disorder—Prednisone—prostate cancer	0.000706	0.000795	CcSEcCtD
Betahistine—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000704	0.000793	CcSEcCtD
Betahistine—Fatigue—Capecitabine—prostate cancer	0.000704	0.000792	CcSEcCtD
Betahistine—Erythema multiforme—Doxorubicin—prostate cancer	0.0007	0.000788	CcSEcCtD
Betahistine—Feeling abnormal—Docetaxel—prostate cancer	0.000695	0.000782	CcSEcCtD
Betahistine—Diarrhoea—Etoposide—prostate cancer	0.000694	0.000781	CcSEcCtD
Betahistine—Flatulence—Epirubicin—prostate cancer	0.000686	0.000773	CcSEcCtD
Betahistine—Feeling abnormal—Capecitabine—prostate cancer	0.000672	0.000757	CcSEcCtD
Betahistine—Dizziness—Etoposide—prostate cancer	0.000671	0.000755	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—prostate cancer	0.000669	0.000753	CcSEcCtD
Betahistine—Urticaria—Capecitabine—prostate cancer	0.000648	0.00073	CcSEcCtD
Betahistine—Ill-defined disorder—Epirubicin—prostate cancer	0.000646	0.000727	CcSEcCtD
Betahistine—Vomiting—Etoposide—prostate cancer	0.000645	0.000726	CcSEcCtD
Betahistine—Dyspepsia—Prednisone—prostate cancer	0.00064	0.00072	CcSEcCtD
Betahistine—Rash—Etoposide—prostate cancer	0.000639	0.00072	CcSEcCtD
Betahistine—Dermatitis—Etoposide—prostate cancer	0.000639	0.000719	CcSEcCtD
Betahistine—Headache—Etoposide—prostate cancer	0.000635	0.000715	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—prostate cancer	0.000635	0.000715	CcSEcCtD
Betahistine—Malaise—Epirubicin—prostate cancer	0.000628	0.000707	CcSEcCtD
Betahistine—Fatigue—Prednisone—prostate cancer	0.000627	0.000705	CcSEcCtD
Betahistine—Hypersensitivity—Docetaxel—prostate cancer	0.000621	0.000699	CcSEcCtD
Betahistine—Asthenia—Docetaxel—prostate cancer	0.000605	0.000681	CcSEcCtD
Betahistine—Convulsion—Epirubicin—prostate cancer	0.000603	0.000679	CcSEcCtD
Betahistine—Nausea—Etoposide—prostate cancer	0.000602	0.000678	CcSEcCtD
Betahistine—Hypersensitivity—Capecitabine—prostate cancer	0.000601	0.000677	CcSEcCtD
Betahistine—Feeling abnormal—Prednisone—prostate cancer	0.000599	0.000674	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—prostate cancer	0.000598	0.000673	CcSEcCtD
Betahistine—Pruritus—Docetaxel—prostate cancer	0.000596	0.000671	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000589	0.000663	CcSEcCtD
Betahistine—Discomfort—Epirubicin—prostate cancer	0.000586	0.00066	CcSEcCtD
Betahistine—Asthenia—Capecitabine—prostate cancer	0.000585	0.000659	CcSEcCtD
Betahistine—Malaise—Doxorubicin—prostate cancer	0.000581	0.000654	CcSEcCtD
Betahistine—Urticaria—Prednisone—prostate cancer	0.000577	0.00065	CcSEcCtD
Betahistine—Pruritus—Capecitabine—prostate cancer	0.000577	0.00065	CcSEcCtD
Betahistine—Diarrhoea—Docetaxel—prostate cancer	0.000577	0.000649	CcSEcCtD
Betahistine—Confusional state—Epirubicin—prostate cancer	0.000573	0.000645	CcSEcCtD
Betahistine—Anaphylactic shock—Epirubicin—prostate cancer	0.000568	0.00064	CcSEcCtD
Betahistine—Convulsion—Doxorubicin—prostate cancer	0.000558	0.000629	CcSEcCtD
Betahistine—Diarrhoea—Capecitabine—prostate cancer	0.000558	0.000628	CcSEcCtD
Betahistine—Nervous system disorder—Epirubicin—prostate cancer	0.000557	0.000628	CcSEcCtD
Betahistine—Dizziness—Docetaxel—prostate cancer	0.000557	0.000627	CcSEcCtD
Betahistine—Tachycardia—Epirubicin—prostate cancer	0.000555	0.000625	CcSEcCtD
Betahistine—Skin disorder—Epirubicin—prostate cancer	0.000552	0.000622	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000545	0.000613	CcSEcCtD
Betahistine—Discomfort—Doxorubicin—prostate cancer	0.000542	0.00061	CcSEcCtD
Betahistine—Dizziness—Capecitabine—prostate cancer	0.00054	0.000607	CcSEcCtD
Betahistine—Vomiting—Docetaxel—prostate cancer	0.000536	0.000603	CcSEcCtD
Betahistine—Hypersensitivity—Prednisone—prostate cancer	0.000536	0.000603	CcSEcCtD
Betahistine—Rash—Docetaxel—prostate cancer	0.000531	0.000598	CcSEcCtD
Betahistine—Dermatitis—Docetaxel—prostate cancer	0.000531	0.000598	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—prostate cancer	0.00053	0.000597	CcSEcCtD
Betahistine—Headache—Docetaxel—prostate cancer	0.000528	0.000594	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000526	0.000592	CcSEcCtD
Betahistine—Asthenia—Prednisone—prostate cancer	0.000521	0.000587	CcSEcCtD
Betahistine—Vomiting—Capecitabine—prostate cancer	0.000519	0.000584	CcSEcCtD
Betahistine—Nervous system disorder—Doxorubicin—prostate cancer	0.000516	0.000581	CcSEcCtD
Betahistine—Rash—Capecitabine—prostate cancer	0.000514	0.000579	CcSEcCtD
Betahistine—Pruritus—Prednisone—prostate cancer	0.000514	0.000579	CcSEcCtD
Betahistine—Dermatitis—Capecitabine—prostate cancer	0.000514	0.000579	CcSEcCtD
Betahistine—Tachycardia—Doxorubicin—prostate cancer	0.000513	0.000578	CcSEcCtD
Betahistine—Headache—Capecitabine—prostate cancer	0.000511	0.000575	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—prostate cancer	0.000511	0.000575	CcSEcCtD
Betahistine—Dyspnoea—Epirubicin—prostate cancer	0.000507	0.00057	CcSEcCtD
Betahistine—Somnolence—Epirubicin—prostate cancer	0.000505	0.000569	CcSEcCtD
Betahistine—Nausea—Docetaxel—prostate cancer	0.000501	0.000564	CcSEcCtD
Betahistine—Dyspepsia—Epirubicin—prostate cancer	0.0005	0.000563	CcSEcCtD
Betahistine—Diarrhoea—Prednisone—prostate cancer	0.000497	0.00056	CcSEcCtD
Betahistine—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000491	0.000552	CcSEcCtD
Betahistine—Fatigue—Epirubicin—prostate cancer	0.00049	0.000552	CcSEcCtD
Betahistine—Nausea—Capecitabine—prostate cancer	0.000485	0.000546	CcSEcCtD
Betahistine—Dizziness—Prednisone—prostate cancer	0.000481	0.000541	CcSEcCtD
Betahistine—Dyspnoea—Doxorubicin—prostate cancer	0.000469	0.000528	CcSEcCtD
Betahistine—Feeling abnormal—Epirubicin—prostate cancer	0.000468	0.000527	CcSEcCtD
Betahistine—Somnolence—Doxorubicin—prostate cancer	0.000468	0.000526	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—prostate cancer	0.000463	0.000521	CcSEcCtD
Betahistine—Vomiting—Prednisone—prostate cancer	0.000462	0.00052	CcSEcCtD
Betahistine—Rash—Prednisone—prostate cancer	0.000458	0.000516	CcSEcCtD
Betahistine—Dermatitis—Prednisone—prostate cancer	0.000458	0.000515	CcSEcCtD
Betahistine—Headache—Prednisone—prostate cancer	0.000455	0.000513	CcSEcCtD
Betahistine—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000454	0.000511	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—prostate cancer	0.000453	0.00051	CcSEcCtD
Betahistine—Urticaria—Epirubicin—prostate cancer	0.000452	0.000508	CcSEcCtD
Betahistine—Feeling abnormal—Doxorubicin—prostate cancer	0.000433	0.000488	CcSEcCtD
Betahistine—Nausea—Prednisone—prostate cancer	0.000432	0.000486	CcSEcCtD
Betahistine—Hypersensitivity—Epirubicin—prostate cancer	0.000419	0.000471	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—prostate cancer	0.000418	0.00047	CcSEcCtD
Betahistine—Asthenia—Epirubicin—prostate cancer	0.000408	0.000459	CcSEcCtD
Betahistine—Pruritus—Epirubicin—prostate cancer	0.000402	0.000453	CcSEcCtD
Betahistine—Diarrhoea—Epirubicin—prostate cancer	0.000389	0.000438	CcSEcCtD
Betahistine—Hypersensitivity—Doxorubicin—prostate cancer	0.000388	0.000436	CcSEcCtD
Betahistine—Asthenia—Doxorubicin—prostate cancer	0.000377	0.000425	CcSEcCtD
Betahistine—Dizziness—Epirubicin—prostate cancer	0.000376	0.000423	CcSEcCtD
Betahistine—Pruritus—Doxorubicin—prostate cancer	0.000372	0.000419	CcSEcCtD
Betahistine—Vomiting—Epirubicin—prostate cancer	0.000361	0.000407	CcSEcCtD
Betahistine—Diarrhoea—Doxorubicin—prostate cancer	0.00036	0.000405	CcSEcCtD
Betahistine—Rash—Epirubicin—prostate cancer	0.000358	0.000403	CcSEcCtD
Betahistine—Dermatitis—Epirubicin—prostate cancer	0.000358	0.000403	CcSEcCtD
Betahistine—Headache—Epirubicin—prostate cancer	0.000356	0.000401	CcSEcCtD
Betahistine—Dizziness—Doxorubicin—prostate cancer	0.000348	0.000392	CcSEcCtD
Betahistine—Nausea—Epirubicin—prostate cancer	0.000338	0.00038	CcSEcCtD
Betahistine—Vomiting—Doxorubicin—prostate cancer	0.000334	0.000376	CcSEcCtD
Betahistine—Rash—Doxorubicin—prostate cancer	0.000332	0.000373	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—prostate cancer	0.000331	0.000373	CcSEcCtD
Betahistine—Headache—Doxorubicin—prostate cancer	0.00033	0.000371	CcSEcCtD
Betahistine—Nausea—Doxorubicin—prostate cancer	0.000312	0.000352	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—ANXA1—prostate cancer	0.00015	0.00135	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCL12—prostate cancer	0.00015	0.00134	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PRKCZ—prostate cancer	0.000147	0.00132	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CG—prostate cancer	0.000144	0.00129	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RGS17—prostate cancer	0.000143	0.00128	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGFR4—prostate cancer	0.000142	0.00128	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PARP1—prostate cancer	0.000142	0.00128	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CALCA—prostate cancer	0.000141	0.00126	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PENK—prostate cancer	0.000139	0.00124	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCL12—prostate cancer	0.000137	0.00123	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—prostate cancer	0.000132	0.00118	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CG—prostate cancer	0.000131	0.00117	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GNRH1—prostate cancer	0.00013	0.00116	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—VIP—prostate cancer	0.00013	0.00116	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CASP9—prostate cancer	0.000129	0.00116	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ADRB2—prostate cancer	0.000128	0.00115	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RLN2—prostate cancer	0.000127	0.00114	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CD—prostate cancer	0.000127	0.00113	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—LPAR1—prostate cancer	0.000126	0.00113	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GRP—prostate cancer	0.000126	0.00113	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PRKCQ—prostate cancer	0.000125	0.00112	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NGFR—prostate cancer	0.000125	0.00112	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PLCB2—prostate cancer	0.000124	0.00111	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAP3K7—prostate cancer	0.000124	0.00111	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CTBP2—prostate cancer	0.000121	0.00109	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HSD17B1—prostate cancer	0.000121	0.00109	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—prostate cancer	0.000121	0.00108	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGF10—prostate cancer	0.000119	0.00107	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PDE4D—prostate cancer	0.000119	0.00106	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GNRH1—prostate cancer	0.000118	0.00106	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—VIP—prostate cancer	0.000118	0.00106	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADRB2—prostate cancer	0.000118	0.00106	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—JAK2—prostate cancer	0.000116	0.00104	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PLXNB1—prostate cancer	0.000116	0.00104	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MAP2K1—prostate cancer	0.000116	0.00104	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CD—prostate cancer	0.000115	0.00103	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—VAV3—prostate cancer	0.000115	0.00103	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—LPAR1—prostate cancer	0.000114	0.00102	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GRP—prostate cancer	0.000114	0.00102	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TGFBR2—prostate cancer	0.000113	0.00101	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PLCB2—prostate cancer	0.000113	0.00101	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GNG5—prostate cancer	0.000113	0.00101	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GRPR—prostate cancer	0.000112	0.001	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ITPR1—prostate cancer	0.000111	0.000999	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CX3CL1—prostate cancer	0.000111	0.000993	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CB—prostate cancer	0.00011	0.000989	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL17RD—prostate cancer	0.000108	0.000968	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PDE4D—prostate cancer	0.000108	0.000966	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IGF1R—prostate cancer	0.000107	0.000955	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCL8—prostate cancer	0.000106	0.000951	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—JAK2—prostate cancer	0.000106	0.000946	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GNG5—prostate cancer	0.000103	0.000919	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LPL—prostate cancer	0.000102	0.000915	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—IL2—prostate cancer	0.000101	0.000908	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PDGFRB—prostate cancer	0.000101	0.000907	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CB—prostate cancer	0.0001	0.000898	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ITGB3—prostate cancer	9.87e-05	0.000884	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PTHLH—prostate cancer	9.84e-05	0.000881	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCL8—prostate cancer	9.63e-05	0.000863	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—WNT4—prostate cancer	9.63e-05	0.000863	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JUP—prostate cancer	9.63e-05	0.000863	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ERBB3—prostate cancer	9.57e-05	0.000858	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGFR2—prostate cancer	9.56e-05	0.000856	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ANXA1—prostate cancer	9.25e-05	0.000829	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL2—prostate cancer	9.21e-05	0.000825	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RALBP1—prostate cancer	9.19e-05	0.000823	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MC2R—prostate cancer	9.19e-05	0.000823	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TERT—prostate cancer	9.17e-05	0.000822	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PTHLH—prostate cancer	8.93e-05	0.0008	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HIF1A—prostate cancer	8.77e-05	0.000786	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PRKACB—prostate cancer	8.74e-05	0.000783	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CALCA—prostate cancer	8.66e-05	0.000776	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LEP—prostate cancer	8.56e-05	0.000767	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PPP3CA—prostate cancer	8.52e-05	0.000763	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CAV1—prostate cancer	8.49e-05	0.00076	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL12—prostate cancer	8.46e-05	0.000758	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ANXA1—prostate cancer	8.4e-05	0.000752	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KDR—prostate cancer	8.39e-05	0.000752	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PENK—prostate cancer	8.19e-05	0.000734	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ESR1—prostate cancer	8.18e-05	0.000733	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	8.14e-05	0.00073	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	8.04e-05	0.00072	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—BAD—prostate cancer	7.98e-05	0.000715	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CALCA—prostate cancer	7.86e-05	0.000705	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GHR—prostate cancer	7.81e-05	0.0007	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—PIK3CA—prostate cancer	7.8e-05	0.000699	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APC—prostate cancer	7.73e-05	0.000693	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CG—prostate cancer	7.73e-05	0.000693	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PRKCQ—prostate cancer	7.72e-05	0.000692	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL12—prostate cancer	7.68e-05	0.000688	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IRS1—prostate cancer	7.64e-05	0.000685	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EGF—prostate cancer	7.64e-05	0.000685	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	7.59e-05	0.00068	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NRP1—prostate cancer	7.49e-05	0.000671	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GSK3B—prostate cancer	7.42e-05	0.000665	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—INS—prostate cancer	7.32e-05	0.000656	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRB2—prostate cancer	7.26e-05	0.00065	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CREBBP—prostate cancer	7.17e-05	0.000642	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IGF1—prostate cancer	7.08e-05	0.000634	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—VAV3—prostate cancer	7.08e-05	0.000634	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—EGFR—prostate cancer	7.04e-05	0.000631	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PRKCQ—prostate cancer	7.01e-05	0.000628	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	6.98e-05	0.000625	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GNRH1—prostate cancer	6.96e-05	0.000624	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VIP—prostate cancer	6.96e-05	0.000624	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ITPR1—prostate cancer	6.86e-05	0.000615	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAP2K1—prostate cancer	6.84e-05	0.000613	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CD—prostate cancer	6.79e-05	0.000609	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GRP—prostate cancer	6.74e-05	0.000604	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LPAR1—prostate cancer	6.74e-05	0.000604	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CA—prostate cancer	6.73e-05	0.000603	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SERPINE1—prostate cancer	6.72e-05	0.000602	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PLCB2—prostate cancer	6.67e-05	0.000598	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LRP2—prostate cancer	6.67e-05	0.000598	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—KRAS—prostate cancer	6.65e-05	0.000596	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRB2—prostate cancer	6.59e-05	0.00059	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CX3CL1—prostate cancer	6.55e-05	0.000587	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—P4HB—prostate cancer	6.55e-05	0.000587	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGF2—prostate cancer	6.51e-05	0.000583	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—VAV3—prostate cancer	6.43e-05	0.000576	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HIST1H2BG—prostate cancer	6.43e-05	0.000576	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOS3—prostate cancer	6.42e-05	0.000575	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDE4D—prostate cancer	6.37e-05	0.000571	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GRB7—prostate cancer	6.37e-05	0.000571	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—JAK2—prostate cancer	6.24e-05	0.000559	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ITPR1—prostate cancer	6.23e-05	0.000558	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HIST1H4H—prostate cancer	6.21e-05	0.000556	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCL8—prostate cancer	6.2e-05	0.000556	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	6.18e-05	0.000554	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CA—prostate cancer	6.11e-05	0.000548	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MDM2—prostate cancer	6.09e-05	0.000545	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GNG5—prostate cancer	6.06e-05	0.000543	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ERBB2—prostate cancer	6e-05	0.000538	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CB—prostate cancer	5.92e-05	0.000531	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCL8—prostate cancer	5.69e-05	0.00051	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN1B—prostate cancer	5.56e-05	0.000498	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AKT1—prostate cancer	5.5e-05	0.000493	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CASP3—prostate cancer	5.45e-05	0.000488	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL2—prostate cancer	5.44e-05	0.000487	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6—prostate cancer	5.41e-05	0.000485	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCND1—prostate cancer	5.3e-05	0.000475	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTHLH—prostate cancer	5.28e-05	0.000473	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TGFBR1—prostate cancer	5.28e-05	0.000473	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CTNNB1—prostate cancer	5.25e-05	0.00047	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKR1C3—prostate cancer	5.19e-05	0.000465	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKACB—prostate cancer	5.16e-05	0.000463	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MMP9—prostate cancer	5.15e-05	0.000461	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN1A—prostate cancer	5.13e-05	0.00046	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTEN—prostate cancer	5.12e-05	0.000459	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PPP3CA—prostate cancer	5.03e-05	0.000451	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—THBS1—prostate cancer	5.03e-05	0.000451	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AKT1—prostate cancer	4.99e-05	0.000447	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ANXA1—prostate cancer	4.96e-05	0.000444	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EP300—prostate cancer	4.88e-05	0.000437	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKCZ—prostate cancer	4.87e-05	0.000436	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CG—prostate cancer	4.76e-05	0.000426	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SRC—prostate cancer	4.75e-05	0.000425	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PARP1—prostate cancer	4.7e-05	0.000421	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGFR4—prostate cancer	4.7e-05	0.000421	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CALCA—prostate cancer	4.65e-05	0.000416	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—VEGFA—prostate cancer	4.62e-05	0.000414	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—STAT3—prostate cancer	4.58e-05	0.00041	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL12—prostate cancer	4.54e-05	0.000407	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CG—prostate cancer	4.32e-05	0.000387	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CASP9—prostate cancer	4.27e-05	0.000383	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MYC—prostate cancer	4.25e-05	0.000381	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TGFB1—prostate cancer	4.24e-05	0.00038	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CD—prostate cancer	4.18e-05	0.000375	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EGFR—prostate cancer	4.16e-05	0.000373	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKCQ—prostate cancer	4.14e-05	0.000371	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NGFR—prostate cancer	4.14e-05	0.000371	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAP3K7—prostate cancer	4.09e-05	0.000367	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF10—prostate cancer	3.93e-05	0.000352	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KRAS—prostate cancer	3.93e-05	0.000352	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRB2—prostate cancer	3.89e-05	0.000349	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—JAK2—prostate cancer	3.84e-05	0.000344	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAP2K1—prostate cancer	3.82e-05	0.000343	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CD—prostate cancer	3.8e-05	0.00034	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VAV3—prostate cancer	3.8e-05	0.00034	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TGFBR2—prostate cancer	3.74e-05	0.000335	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ITPR1—prostate cancer	3.68e-05	0.00033	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CB—prostate cancer	3.65e-05	0.000327	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CA—prostate cancer	3.61e-05	0.000323	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IGF1R—prostate cancer	3.52e-05	0.000315	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	3.5e-05	0.000314	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TP53—prostate cancer	3.49e-05	0.000313	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—JAK2—prostate cancer	3.49e-05	0.000312	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LPL—prostate cancer	3.38e-05	0.000302	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—IL2—prostate cancer	3.35e-05	0.0003	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDGFRB—prostate cancer	3.34e-05	0.0003	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	3.31e-05	0.000297	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ITGB3—prostate cancer	3.26e-05	0.000292	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6—prostate cancer	3.2e-05	0.000286	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL8—prostate cancer	3.18e-05	0.000285	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ERBB3—prostate cancer	3.16e-05	0.000283	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGFR2—prostate cancer	3.16e-05	0.000283	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL2—prostate cancer	3.04e-05	0.000273	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TERT—prostate cancer	3.03e-05	0.000272	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKT1—prostate cancer	2.95e-05	0.000264	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HIF1A—prostate cancer	2.9e-05	0.00026	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LEP—prostate cancer	2.83e-05	0.000253	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CAV1—prostate cancer	2.8e-05	0.000251	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KDR—prostate cancer	2.77e-05	0.000248	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ESR1—prostate cancer	2.7e-05	0.000242	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—BAD—prostate cancer	2.64e-05	0.000236	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	2.55e-05	0.000229	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APC—prostate cancer	2.55e-05	0.000229	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EGF—prostate cancer	2.52e-05	0.000226	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IRS1—prostate cancer	2.52e-05	0.000226	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GSK3B—prostate cancer	2.45e-05	0.00022	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—INS—prostate cancer	2.42e-05	0.000217	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CREBBP—prostate cancer	2.37e-05	0.000212	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IGF1—prostate cancer	2.34e-05	0.000209	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EGFR—prostate cancer	2.33e-05	0.000208	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	2.26e-05	0.000202	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	2.24e-05	0.000201	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	2.22e-05	0.000199	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	2.22e-05	0.000199	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—KRAS—prostate cancer	2.2e-05	0.000197	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF2—prostate cancer	2.15e-05	0.000193	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOS3—prostate cancer	2.12e-05	0.00019	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JAK2—prostate cancer	2.06e-05	0.000185	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	2.02e-05	0.000181	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MDM2—prostate cancer	2.01e-05	0.00018	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ERBB2—prostate cancer	1.98e-05	0.000178	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	1.96e-05	0.000175	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL8—prostate cancer	1.88e-05	0.000168	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	1.84e-05	0.000165	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	1.82e-05	0.000163	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CASP3—prostate cancer	1.8e-05	0.000161	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL2—prostate cancer	1.8e-05	0.000161	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6—prostate cancer	1.79e-05	0.00016	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCND1—prostate cancer	1.75e-05	0.000157	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	1.73e-05	0.000155	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MMP9—prostate cancer	1.7e-05	0.000152	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.69e-05	0.000152	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTEN—prostate cancer	1.69e-05	0.000151	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.65e-05	0.000148	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EP300—prostate cancer	1.61e-05	0.000144	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SRC—prostate cancer	1.57e-05	0.00014	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.53e-05	0.000137	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT3—prostate cancer	1.51e-05	0.000135	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MYC—prostate cancer	1.4e-05	0.000126	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.4e-05	0.000126	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EGFR—prostate cancer	1.37e-05	0.000123	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KRAS—prostate cancer	1.3e-05	0.000116	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.19e-05	0.000107	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TP53—prostate cancer	1.15e-05	0.000103	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6—prostate cancer	1.06e-05	9.46e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKT1—prostate cancer	9.74e-06	8.73e-05	CbGpPWpGaD
